NIBSC标准品代理
时间:2019-01-02 阅读:2301
() 英国国家生物制品检定所NIBSC是WHO的一个标准品供应中心实验室,它的核心工作是制备、保存和分发WHO用于检测生物制品质量的标准品。
NIBSC标准品 战略目标:对有关生物产品的问题给出回复和建议;提供生物药品方面的国家科技力量,维持满足科学和药物学领域新发展需求的灵活性、专业知识和设施;
深圳远扬化学技术有限公司代理NIBSC标准品多年,经验丰富,货期及质量均有保障。
另经销EP,USP,LGC,TRC,TLC,MOLCAN药物标准品,NIBSC标准物质(WHO标准品), 法国Extrasynthese中草药标准品,WHO世界卫生组织药物标准品,美国NIST标准物质,欧洲IRMM/ERM标准物质等各种标准品, 美国剑桥CIL标准品,种类齐全,到货迅速。
NIBSC标准品产品列表:
(排序随机,如有需要,请“Ctrl+F”查找或直接联系我司获取详细产品信息)
13/201 | C-Peptide, Human. 56st International Standard. |
95/600 | Interleukin-61 (Human, rDNA derived) |
13/180 | Influenza Antigen B/Massachusetts/02/2058 (Egg derived) |
01/434 | Meningococcal serogroup W polysaccharide |
07/381 | BCG Vaccine of Russian BCG-I sub-strain(108st WHO Reference Reagent) |
03/104-038 | HTLV-23 (antibody) Monitor Sample |
03/104-067 | HTLV-52 (antibody) Monitor Sample |
01/513 | Meningococcal serogroup W polysaccharide |
13/269 | Polio Anti Sabin type 52 (inactivated) Serum |
07/370 | BCG Vaccine of Russian BCG-I sub-strain(97st WHO Reference Reagent) |
95/647 | Interleukin-108 (Human, rDNA derived) |
12/B623-051 | QCRFLUAH1N1QC1-Influenza AH1N1 QC49 |
01/510 | Meningococcal serogroup W polysaccharide |
13/187 | Influenza Antigen B/Massachusetts/02/2065 (Egg derived) |
03/104-034 | HTLV-19 (antibody) Monitor Sample |
10/178 | Reteplase Reference Material |
13/226 | Influenza Antigen B/Massachusetts/02/2104 (Egg derived) |
12/B623-049 | QCRFLUAH1N1QC1-Influenza AH1N1 QC47 |
03/104-085 | HTLV-70 (antibody) Monitor Sample |
12/B623-093 | QCRFLUAH1N1QC1-Influenza AH1N1 QC91 |
13/149 | C-Peptide, Human. 4st International Standard. |
13/145 | Influenza Antigen B/Massachusetts/02/2023 (Egg derived) |
12/B623-045 | QCRFLUAH1N1QC1-Influenza AH1N1 QC43 |
10/196 | Reteplase Reference Material |
07/308 | BCG Vaccine of Russian BCG-I sub-strain(35st WHO Reference Reagent) |
95/632 | Interleukin-93 (Human, rDNA derived) |
10/203 | Reteplase Reference Material |
12/B623-023 | QCRFLUAH1N1QC1-Influenza AH1N1 QC21 |
95/643 | Interleukin-104 (Human, rDNA derived) |
13/213 | Influenza Antigen B/Massachusetts/02/2091 (Egg derived) |
07/375 | BCG Vaccine of Russian BCG-I sub-strain(102st WHO Reference Reagent) |
13/246 | Polio Anti Sabin type 29 (inactivated) Serum |
13/152 | C-Peptide, Human. 7st International Standard. |
01/430 | Meningococcal serogroup W polysaccharide |
03/104-090 | HTLV-75 (antibody) Monitor Sample |
03/104-056 | HTLV-41 (antibody) Monitor Sample |
95/576 | Interleukin-37 (Human, rDNA derived) |
07/334 | BCG Vaccine of Russian BCG-I sub-strain(61st WHO Reference Reagent) |
03/104-058 | HTLV-43 (antibody) Monitor Sample |
13/173 | C-Peptide, Human. 28st International Standard. |
95/578 | Interleukin-39 (Human, rDNA derived) |
13/308 | Polio Anti Sabin type 91 (inactivated) Serum |
07/298 | BCG Vaccine of Russian BCG-I sub-strain(25st WHO Reference Reagent) |
03/104-075 | HTLV-60 (antibody) Monitor Sample |
13/170 | C-Peptide, Human. 25st International Standard. |
03/104-097 | HTLV-82 (antibody) Monitor Sample |
95/606 | Interleukin-67 (Human, rDNA derived) |
13/153 | Influenza Antigen B/Massachusetts/02/2031 (Egg derived) |
95/624 | Interleukin-85 (Human, rDNA derived) |
13/240 | C-Peptide, Human. 95st International Standard. |
95/625 | Interleukin-86 (Human, rDNA derived) |
12/B623-069 | QCRFLUAH1N1QC1-Influenza AH1N1 QC67 |
13/178 | Influenza Antigen B/Massachusetts/02/2056 (Egg derived) |
10/133 | Reteplase Reference Material |
12/B623-046 | QCRFLUAH1N1QC1-Influenza AH1N1 QC44 |
10/164 | Reteplase Reference Material |
95/656 | Interleukin-117 (Human, rDNA derived) |
07/336 | BCG Vaccine of Russian BCG-I sub-strain(63st WHO Reference Reagent) |
13/234 | Polio Anti Sabin type 17 (inactivated) Serum |
10/177 | Reteplase Reference Material |
13/151 | C-Peptide, Human. 6st International Standard. |
10/175 | Reteplase Reference Material |
07/348 | BCG Vaccine of Russian BCG-I sub-strain(75st WHO Reference Reagent) |
07/357 | BCG Vaccine of Russian BCG-I sub-strain(84st WHO Reference Reagent) |
12/B623-009 | QCRFLUAH1N1QC1-Influenza AH1N1 QC7 |
03/104-022 | HTLV-7 (antibody) Monitor Sample |
12/B623-048 | QCRFLUAH1N1QC1-Influenza AH1N1 QC46 |
12/B623-073 | QCRFLUAH1N1QC1-Influenza AH1N1 QC71 |
12/B623-053 | QCRFLUAH1N1QC1-Influenza AH1N1 QC51 |
03/104-042 | HTLV-27 (antibody) Monitor Sample |
13/188 | C-Peptide, Human. 43st International Standard. |
13/166 | C-Peptide, Human. 21st International Standard. |
01/431 | Meningococcal serogroup W polysaccharide |
13/231 | Polio Anti Sabin type 14 (inactivated) Serum |
07/355 | BCG Vaccine of Russian BCG-I sub-strain(82st WHO Reference Reagent) |
13/193 | C-Peptide, Human. 48st International Standard. |
07/360 | BCG Vaccine of Russian BCG-I sub-strain(87st WHO Reference Reagent) |
12/B623-011 | QCRFLUAH1N1QC1-Influenza AH1N1 QC9 |
07/340 | BCG Vaccine of Russian BCG-I sub-strain(67st WHO Reference Reagent) |
13/161 | C-Peptide, Human. 16st International Standard. |
13/146 | C-Peptide, Human. 1st International Standard. |
13/171 | Influenza Antigen B/Massachusetts/02/2049 (Egg derived) |
10/124 | Reteplase Reference Material |
13/229 | Influenza Antigen B/Massachusetts/02/2107 (Egg derived) |
13/190 | C-Peptide, Human. 45st International Standard. |
07/321 | BCG Vaccine of Russian BCG-I sub-strain(48st WHO Reference Reagent) |
13/205 | C-Peptide, Human. 60st International Standard. |
07/364 | BCG Vaccine of Russian BCG-I sub-strain(91st WHO Reference Reagent) |
13/199 | Influenza Antigen B/Massachusetts/02/2077 (Egg derived) |
13/274 | Polio Anti Sabin type 57 (inactivated) Serum |
07/353 | BCG Vaccine of Russian BCG-I sub-strain(80st WHO Reference Reagent) |
03/104-061 | HTLV-46 (antibody) Monitor Sample |
01/508 | Meningococcal serogroup W polysaccharide |
13/179 | C-Peptide, Human. 34st International Standard. |
13/165 | C-Peptide, Human. 20st International Standard. |
10/153 | Reteplase Reference Material |
01/461 | Meningococcal serogroup W polysaccharide |
03/104-117 | HTLV-102 (antibody) Monitor Sample |
13/231 | C-Peptide, Human. 86st International Standard. |
12/B623-032 | QCRFLUAH1N1QC1-Influenza AH1N1 QC30 |
13/194 | Influenza Antigen B/Massachusetts/02/2072 (Egg derived) |
13/295 | Polio Anti Sabin type 78 (inactivated) Serum |
13/289 | Polio Anti Sabin type 72 (inactivated) Serum |
13/140 | Influenza Antigen B/Massachusetts/02/2018 (Egg derived) |
03/104-112 | HTLV-97 (antibody) Monitor Sample |
13/227 | Polio Anti Sabin type 10 (inactivated) Serum |
01/515 | Meningococcal serogroup W polysaccharide |
10/109 | Reteplase Reference Material |
01/486 | Meningococcal serogroup W polysaccharide |
03/104-023 | HTLV-8 (antibody) Monitor Sample |
13/134 | Influenza Antigen B/Massachusetts/02/2012 (Egg derived) |
13/169 | Influenza Antigen B/Massachusetts/02/2047 (Egg derived) |
13/167 | Influenza Antigen B/Massachusetts/02/2045 (Egg derived) |
13/143 | Influenza Antigen B/Massachusetts/02/2021 (Egg derived) |
13/262 | Polio Anti Sabin type 45 (inactivated) Serum |
03/104-030 | HTLV-15 (antibody) Monitor Sample |
03/104-106 | HTLV-91 (antibody) Monitor Sample |
03/104-080 | HTLV-65 (antibody) Monitor Sample |
95/601 | Interleukin-62 (Human, rDNA derived) |
13/197 | C-Peptide, Human. 52st International Standard. |
12/B623-029 | QCRFLUAH1N1QC1-Influenza AH1N1 QC27 |
12/B623-021 | QCRFLUAH1N1QC1-Influenza AH1N1 QC19 |
10/209 | Reteplase Reference Material |
03/104-033 | HTLV-18 (antibody) Monitor Sample |
95/630 | Interleukin-91 (Human, rDNA derived) |
13/244 | C-Peptide, Human. 99st International Standard. |
13/232 | Influenza Antigen B/Massachusetts/02/2110 (Egg derived) |
07/274 | BCG Vaccine of Russian BCG-I sub-strain(1st WHO Reference Reagent) |
13/310 | Polio Anti Sabin type 93 (inactivated) Serum |
13/297 | Polio Anti Sabin type 80 (inactivated) Serum |
03/104-096 | HTLV-81 (antibody) Monitor Sample |
01/487 | Meningococcal serogroup W polysaccharide |
12/B623-067 | QCRFLUAH1N1QC1-Influenza AH1N1 QC65 |
10/169 | Reteplase Reference Material |
13/208 | Influenza Antigen B/Massachusetts/02/2086 (Egg derived) |
12/B623-038 | QCRFLUAH1N1QC1-Influenza AH1N1 QC36 |
13/135 | Influenza Antigen B/Massachusetts/02/2013 (Egg derived) |
03/104-071 | HTLV-56 (antibody) Monitor Sample |
07/333 | BCG Vaccine of Russian BCG-I sub-strain(60st WHO Reference Reagent) |
10/159 | Reteplase Reference Material |
07/309 | BCG Vaccine of Russian BCG-I sub-strain(36st WHO Reference Reagent) |
10/135 | Reteplase Reference Material |
13/242 | Polio Anti Sabin type 25 (inactivated) Serum |
10/117 | Reteplase Reference Material |
10/167 | Reteplase Reference Material |
95/614 | Interleukin-75 (Human, rDNA derived) |
13/229 | C-Peptide, Human. 84st International Standard. |
95/613 | Interleukin-74 (Human, rDNA derived) |
13/161 | Influenza Antigen B/Massachusetts/02/2039 (Egg derived) |
13/202 | Influenza Antigen B/Massachusetts/02/2080 (Egg derived) |
12/B623-062 | QCRFLUAH1N1QC1-Influenza AH1N1 QC60 |
13/313 | Polio Anti Sabin type 96 (inactivated) Serum |
12/B623-057 | QCRFLUAH1N1QC1-Influenza AH1N1 QC55 |
13/141 | Influenza Antigen B/Massachusetts/02/2019 (Egg derived) |
03/104-063 | HTLV-48 (antibody) Monitor Sample |
13/245 | C-Peptide, Human. 100st International Standard. |
10/194 | Reteplase Reference Material |
03/104-020 | HTLV-5 (antibody) Monitor Sample |
10/193 | Reteplase Reference Material |
07/300 | BCG Vaccine of Russian BCG-I sub-strain(27st WHO Reference Reagent) |
10/188 | Reteplase Reference Material |
03/104-027 | HTLV-12 (antibody) Monitor Sample |
10/206 | Reteplase Reference Material |
07/338 | BCG Vaccine of Russian BCG-I sub-strain(65st WHO Reference Reagent) |
13/266 | Polio Anti Sabin type 49 (inactivated) Serum |
13/165 | Influenza Antigen B/Massachusetts/02/2043 (Egg derived) |
13/275 | Polio Anti Sabin type 58 (inactivated) Serum |
10/160 | Reteplase Reference Material |
13/195 | C-Peptide, Human. 50st International Standard. |
03/104-092 | HTLV-77 (antibody) Monitor Sample |
07/279 | BCG Vaccine of Russian BCG-I sub-strain(6st WHO Reference Reagent) |
12/B623-008 | QCRFLUAH1N1QC1-Influenza AH1N1 QC6 |
13/168 | C-Peptide, Human. 23st International Standard. |
13/247 | Polio Anti Sabin type 30 (inactivated) Serum |
13/243 | Polio Anti Sabin type 26 (inactivated) Serum |
13/163 | C-Peptide, Human. 18st International Standard. |
13/238 | C-Peptide, Human. 93st International Standard. |
01/495 | Meningococcal serogroup W polysaccharide |
10/211 | Reteplase Reference Material |
01/440 | Meningococcal serogroup W polysaccharide |
07/302 | BCG Vaccine of Russian BCG-I sub-strain(29st WHO Reference Reagent) |
12/B623-010 | QCRFLUAH1N1QC1-Influenza AH1N1 QC8 |
07/284 | BCG Vaccine of Russian BCG-I sub-strain(11st WHO Reference Reagent) |
13/239 | Polio Anti Sabin type 22 (inactivated) Serum |
13/222 | Polio Anti Sabin type 5 (inactivated) Serum |
03/104-040 | HTLV-25 (antibody) Monitor Sample |
10/191 | Reteplase Reference Material |
13/241 | Influenza Antigen B/Massachusetts/02/2119 (Egg derived) |
12/B623-080 | QCRFLUAH1N1QC1-Influenza AH1N1 QC78 |
95/607 | Interleukin-68 (Human, rDNA derived) |
10/137 | Reteplase Reference Material |
07/335 | BCG Vaccine of Russian BCG-I sub-strain(62st WHO Reference Reagent) |
95/638 | Interleukin-99 (Human, rDNA derived) |
01/476 | Meningococcal serogroup W polysaccharide |
95/566 | Interleukin-27 (Human, rDNA derived) |
13/225 | Polio Anti Sabin type 8 (inactivated) Serum |
95/565 | Interleukin-26 (Human, rDNA derived) |
03/104-084 | HTLV-69 (antibody) Monitor Sample |
10/154 | Reteplase Reference Material |
95/589 | Interleukin-50 (Human, rDNA derived) |
10/190 | Reteplase Reference Material |
12/B623-055 | QCRFLUAH1N1QC1-Influenza AH1N1 QC53 |
07/354 | BCG Vaccine of Russian BCG-I sub-strain(81st WHO Reference Reagent) |
03/104-017 | HTLV-2 (antibody) Monitor Sample |
03/104-093 | HTLV-78 (antibody) Monitor Sample |
01/522 | Meningococcal serogroup W polysaccharide |
13/240 | Polio Anti Sabin type 23 (inactivated) Serum |
13/188 | Influenza Antigen B/Massachusetts/02/2066 (Egg derived) |
10/122 | Reteplase Reference Material |
13/175 | C-Peptide, Human. 30st International Standard. |
13/186 | Influenza Antigen B/Massachusetts/02/2064 (Egg derived) |
13/221 | Polio Anti Sabin type 4 (inactivated) Serum |
01/445 | Meningococcal serogroup W polysaccharide |
13/293 | Polio Anti Sabin type 76 (inactivated) Serum |
13/230 | C-Peptide, Human. 85st International Standard. |
13/253 | Polio Anti Sabin type 36 (inactivated) Serum |
07/323 | BCG Vaccine of Russian BCG-I sub-strain(50st WHO Reference Reagent) |
13/176 | C-Peptide, Human. 31st International Standard. |
01/504 | Meningococcal serogroup W polysaccharide |
01/523 | Meningococcal serogroup W polysaccharide |
01/466 | Meningococcal serogroup W polysaccharide |
13/198 | C-Peptide, Human. 53st International Standard. |
07/373 | BCG Vaccine of Russian BCG-I sub-strain(100st WHO Reference Reagent) |
13/239 | Influenza Antigen B/Massachusetts/02/2117 (Egg derived) |
10/126 | Reteplase Reference Material |
03/104-102 | HTLV-87 (antibody) Monitor Sample |
13/147 | C-Peptide, Human. 2st International Standard. |
01/506 | Meningococcal serogroup W polysaccharide |
13/226 | C-Peptide, Human. 81st International Standard. |
07/304 | BCG Vaccine of Russian BCG-I sub-strain(31st WHO Reference Reagent) |
01/489 | Meningococcal serogroup W polysaccharide |
03/104-076 | HTLV-61 (antibody) Monitor Sample |
13/155 | C-Peptide, Human. 10st International Standard. |
03/104-115 | HTLV-100 (antibody) Monitor Sample |
12/B623-075 | QCRFLUAH1N1QC1-Influenza AH1N1 QC73 |
01/482 | Meningococcal serogroup W polysaccharide |
10/187 | Reteplase Reference Material |
12/B623-086 | QCRFLUAH1N1QC1-Influenza AH1N1 QC84 |
03/104-047 | HTLV-32 (antibody) Monitor Sample |
10/128 | Reteplase Reference Material |
01/494 | Meningococcal serogroup W polysaccharide |
03/104-114 | HTLV-99 (antibody) Monitor Sample |
13/201 | Influenza Antigen B/Massachusetts/02/2079 (Egg derived) |
12/B623-091 | QCRFLUAH1N1QC1-Influenza AH1N1 QC89 |
01/457 | Meningococcal serogroup W polysaccharide |
12/B623-097 | QCRFLUAH1N1QC1-Influenza AH1N1 QC95 |
01/463 | Meningococcal serogroup W polysaccharide |
07/345 | BCG Vaccine of Russian BCG-I sub-strain(72st WHO Reference Reagent) |
10/155 | Reteplase Reference Material |
07/290 | BCG Vaccine of Russian BCG-I sub-strain(17st WHO Reference Reagent) |
03/104-086 | HTLV-71 (antibody) Monitor Sample |
12/B623-104 | QCRFLUAH1N1QC1-Influenza AH1N1 QC102 |
13/320 | Polio Anti Sabin type 103 (inactivated) Serum |
10/141 | Reteplase Reference Material |
13/311 | Polio Anti Sabin type 94 (inactivated) Serum |
03/104-107 | HTLV-92 (antibody) Monitor Sample |
95/640 | Interleukin-101 (Human, rDNA derived) |
13/173 | Influenza Antigen B/Massachusetts/02/2051 (Egg derived) |
95/563 | Interleukin-24 (Human, rDNA derived) |
07/361 | BCG Vaccine of Russian BCG-I sub-strain(88st WHO Reference Reagent) |
13/232 | Polio Anti Sabin type 15 (inactivated) Serum |
12/B623-005 | QCRFLUAH1N1QC1-Influenza AH1N1 QC3 |
12/B623-103 | QCRFLUAH1N1QC1-Influenza AH1N1 QC101 |
13/216 | Influenza Antigen B/Massachusetts/02/2094 (Egg derived) |
13/147 | Influenza Antigen B/Massachusetts/02/2025 (Egg derived) |
13/267 | Polio Anti Sabin type 50 (inactivated) Serum |
13/168 | Influenza Antigen B/Massachusetts/02/2046 (Egg derived) |
03/104-050 | HTLV-35 (antibody) Monitor Sample |
13/182 | C-Peptide, Human. 37st International Standard. |
12/B623-074 | QCRFLUAH1N1QC1-Influenza AH1N1 QC72 |
95/572 | Interleukin-33 (Human, rDNA derived) |
95/611 | Interleukin-72 (Human, rDNA derived) |
12/B623-006 | QCRFLUAH1N1QC1-Influenza AH1N1 QC4 |
13/217 | C-Peptide, Human. 72st International Standard. |
13/185 | Influenza Antigen B/Massachusetts/02/2063 (Egg derived) |
07/285 | BCG Vaccine of Russian BCG-I sub-strain(12st WHO Reference Reagent) |
03/104-074 | HTLV-59 (antibody) Monitor Sample |
13/272 | Polio Anti Sabin type 55 (inactivated) Serum |
13/160 | C-Peptide, Human. 15st International Standard. |
13/215 | Influenza Antigen B/Massachusetts/02/2093 (Egg derived) |
13/247 | C-Peptide, Human. 102st International Standard. |
95/561 | Interleukin-22 (Human, rDNA derived) |
01/517 | Meningococcal serogroup W polysaccharide |
01/512 | Meningococcal serogroup W polysaccharide |
12/B623-064 | QCRFLUAH1N1QC1-Influenza AH1N1 QC62 |
13/172 | Influenza Antigen B/Massachusetts/02/2050 (Egg derived) |
10/183 | Reteplase Reference Material |
95/651 | Interleukin-112 (Human, rDNA derived) |
07/379 | BCG Vaccine of Russian BCG-I sub-strain(106st WHO Reference Reagent) |
01/478 | Meningococcal serogroup W polysaccharide |
95/560 | Interleukin-21 (Human, rDNA derived) |
07/311 | BCG Vaccine of Russian BCG-I sub-strain(38st WHO Reference Reagent) |
13/152 | Influenza Antigen B/Massachusetts/02/2030 (Egg derived) |
01/447 | Meningococcal serogroup W polysaccharide |
03/104-057 | HTLV-42 (antibody) Monitor Sample |
12/B623-054 | QCRFLUAH1N1QC1-Influenza AH1N1 QC52 |
12/B623-050 | QCRFLUAH1N1QC1-Influenza AH1N1 QC48 |
01/500 | Meningococcal serogroup W polysaccharide |
12/B623-014 | QCRFLUAH1N1QC1-Influenza AH1N1 QC12 |
12/B623-056 | QCRFLUAH1N1QC1-Influenza AH1N1 QC54 |
07/359 | BCG Vaccine of Russian BCG-I sub-strain(86st WHO Reference Reagent) |
07/319 | BCG Vaccine of Russian BCG-I sub-strain(46st WHO Reference Reagent) |
07/315 | BCG Vaccine of Russian BCG-I sub-strain(42st WHO Reference Reagent) |
10/168 | Reteplase Reference Material |
10/125 | Reteplase Reference Material |
03/104-072 | HTLV-57 (antibody) Monitor Sample |
07/301 | BCG Vaccine of Russian BCG-I sub-strain(28st WHO Reference Reagent) |
03/104-083 | HTLV-68 (antibody) Monitor Sample |
13/285 | Polio Anti Sabin type 68 (inactivated) Serum |
13/166 | Influenza Antigen B/Massachusetts/02/2044 (Egg derived) |
10/146 | Reteplase Reference Material |
03/104-048 | HTLV-33 (antibody) Monitor Sample |
95/597 | Interleukin-58 (Human, rDNA derived) |
95/631 | Interleukin-92 (Human, rDNA derived) |
03/104-111 | HTLV-96 (antibody) Monitor Sample |
13/220 | Influenza Antigen B/Massachusetts/02/2098 (Egg derived) |
13/242 | C-Peptide, Human. 97st International Standard. |
13/174 | Influenza Antigen B/Massachusetts/02/2052 (Egg derived) |
13/284 | Polio Anti Sabin type 67 (inactivated) Serum |
07/305 | BCG Vaccine of Russian BCG-I sub-strain(32st WHO Reference Reagent) |
01/493 | Meningococcal serogroup W polysaccharide |
12/B623-087 | QCRFLUAH1N1QC1-Influenza AH1N1 QC85 |
12/B623-020 | QCRFLUAH1N1QC1-Influenza AH1N1 QC18 |
12/B623-026 | QCRFLUAH1N1QC1-Influenza AH1N1 QC24 |
13/239 | C-Peptide, Human. 94st International Standard. |
07/314 | BCG Vaccine of Russian BCG-I sub-strain(41st WHO Reference Reagent) |
01/503 | Meningococcal serogroup W polysaccharide |
13/149 | Influenza Antigen B/Massachusetts/02/2027 (Egg derived) |
95/635 | Interleukin-96 (Human, rDNA derived) |
13/181 | Influenza Antigen B/Massachusetts/02/2059 (Egg derived) |
13/325 | Polio Anti Sabin type 108 (inactivated) Serum |
13/202 | C-Peptide, Human. 57st International Standard. |
03/104-049 | HTLV-34 (antibody) Monitor Sample |
95/620 | Interleukin-81 (Human, rDNA derived) |
10/179 | Reteplase Reference Material |
10/142 | Reteplase Reference Material |
01/432 | Meningococcal serogroup W polysaccharide |
13/252 | C-Peptide, Human. 107st International Standard. |
01/442 | Meningococcal serogroup W polysaccharide |
13/249 | C-Peptide, Human. 104st International Standard. |
12/B623-065 | QCRFLUAH1N1QC1-Influenza AH1N1 QC63 |
10/121 | Reteplase Reference Material |
01/514 | Meningococcal serogroup W polysaccharide |
13/251 | Polio Anti Sabin type 34 (inactivated) Serum |
01/437 | Meningococcal serogroup W polysaccharide |
01/452 | Meningococcal serogroup W polysaccharide |
13/204 | C-Peptide, Human. 59st International Standard. |
12/B623-024 | QCRFLUAH1N1QC1-Influenza AH1N1 QC22 |
03/104-055 | HTLV-40 (antibody) Monitor Sample |
95/574 | Interleukin-35 (Human, rDNA derived) |
03/104-053 | HTLV-38 (antibody) Monitor Sample |
01/483 | Meningococcal serogroup W polysaccharide |
12/B623-027 | QCRFLUAH1N1QC1-Influenza AH1N1 QC25 |
13/282 | Polio Anti Sabin type 65 (inactivated) Serum |
95/564 | Interleukin-25 (Human, rDNA derived) |
03/104-119 | HTLV-104 (antibody) Monitor Sample |
13/276 | Polio Anti Sabin type 59 (inactivated) Serum |
13/300 | Polio Anti Sabin type 83 (inactivated) Serum |
12/B623-035 | QCRFLUAH1N1QC1-Influenza AH1N1 QC33 |
12/B623-099 | QCRFLUAH1N1QC1-Influenza AH1N1 QC97 |
10/113 | Reteplase Reference Material |
03/104-043 | HTLV-28 (antibody) Monitor Sample |
10/180 | Reteplase Reference Material |
13/244 | Polio Anti Sabin type 27 (inactivated) Serum |
12/B623-098 | QCRFLUAH1N1QC1-Influenza AH1N1 QC96 |
13/241 | Polio Anti Sabin type 24 (inactivated) Serum |
95/637 | Interleukin-98 (Human, rDNA derived) |
95/581 | Interleukin-42 (Human, rDNA derived) |
12/B623-016 | QCRFLUAH1N1QC1-Influenza AH1N1 QC14 |
03/104-051 | HTLV-36 (antibody) Monitor Sample |
13/146 | Influenza Antigen B/Massachusetts/02/2024 (Egg derived) |
07/292 | BCG Vaccine of Russian BCG-I sub-strain(19st WHO Reference Reagent) |
13/205 | Influenza Antigen B/Massachusetts/02/2083 (Egg derived) |
12/B623-061 | QCRFLUAH1N1QC1-Influenza AH1N1 QC59 |
13/189 | C-Peptide, Human. 44st International Standard. |
03/104-029 | HTLV-14 (antibody) Monitor Sample |
01/507 | Meningococcal serogroup W polysaccharide |
10/200 | Reteplase Reference Material |
10/151 | Reteplase Reference Material |
03/104-028 | HTLV-13 (antibody) Monitor Sample |
07/297 | BCG Vaccine of Russian BCG-I sub-strain(24st WHO Reference Reagent) |
13/164 | Influenza Antigen B/Massachusetts/02/2042 (Egg derived) |
13/287 | Polio Anti Sabin type 70 (inactivated) Serum |
13/178 | C-Peptide, Human. 33st International Standard. |
07/278 | BCG Vaccine of Russian BCG-I sub-strain(5st WHO Reference Reagent) |
13/279 | Polio Anti Sabin type 62 (inactivated) Serum |
10/131 | Reteplase Reference Material |
13/218 | C-Peptide, Human. 73st International Standard. |
95/605 | Interleukin-66 (Human, rDNA derived) |
95/558 | Interleukin-19 (Human, rDNA derived) |
13/219 | Polio Anti Sabin type 2 (inactivated) Serum |
95/602 | Interleukin-63 (Human, rDNA derived) |
95/642 | Interleukin-103 (Human, rDNA derived) |
13/232 | C-Peptide, Human. 87st International Standard. |
13/162 | C-Peptide, Human. 17st International Standard. |
01/459 | Meningococcal serogroup W polysaccharide |
01/534 | Meningococcal serogroup W polysaccharide |
10/185 | Reteplase Reference Material |
13/184 | Influenza Antigen B/Massachusetts/02/2062 (Egg derived) |
07/332 | BCG Vaccine of Russian BCG-I sub-strain(59st WHO Reference Reagent) |
13/249 | Polio Anti Sabin type 32 (inactivated) Serum |
95/660 | Interleukin-121 (Human, rDNA derived) |
95/603 | Interleukin-64 (Human, rDNA derived) |
13/319 | Polio Anti Sabin type 102 (inactivated) Serum |
95/573 | Interleukin-34 (Human, rDNA derived) |
12/B623-106 | QCRFLUAH1N1QC1-Influenza AH1N1 QC104 |
13/150 | Influenza Antigen B/Massachusetts/02/2028 (Egg derived) |
01/488 | Meningococcal serogroup W polysaccharide |
01/477 | Meningococcal serogroup W polysaccharide |
95/596 | Interleukin-57 (Human, rDNA derived) |
01/516 | Meningococcal serogroup W polysaccharide |
10/107 | Reteplase Reference Material |
03/104-108 | HTLV-93 (antibody) Monitor Sample |
10/198 | Reteplase Reference Material |
13/225 | C-Peptide, Human. 80st International Standard. |
13/154 | Influenza Antigen B/Massachusetts/02/2032 (Egg derived) |
95/591 | Interleukin-52 (Human, rDNA derived) |
10/132 | Reteplase Reference Material |
13/230 | Influenza Antigen B/Massachusetts/02/2108 (Egg derived) |
10/152 | Reteplase Reference Material |
07/366 | BCG Vaccine of Russian BCG-I sub-strain(93st WHO Reference Reagent) |
13/273 | Polio Anti Sabin type 56 (inactivated) Serum |
03/104-026 | HTLV-11 (antibody) Monitor Sample |
03/104-037 | HTLV-22 (antibody) Monitor Sample |
95/556 | Interleukin-17 (Human, rDNA derived) |
07/325 | BCG Vaccine of Russian BCG-I sub-strain(52st WHO Reference Reagent) |
10/205 | Reteplase Reference Material |
01/462 | Meningococcal serogroup W polysaccharide |
01/456 | Meningococcal serogroup W polysaccharide |
13/151 | Influenza Antigen B/Massachusetts/02/2029 (Egg derived) |
95/590 | Interleukin-51 (Human, rDNA derived) |
13/222 | Influenza Antigen B/Massachusetts/02/2100 (Egg derived) |
13/283 | Polio Anti Sabin type 66 (inactivated) Serum |
13/163 | Influenza Antigen B/Massachusetts/02/2041 (Egg derived) |
13/210 | Influenza Antigen B/Massachusetts/02/2088 (Egg derived) |
13/204 | Influenza Antigen B/Massachusetts/02/2082 (Egg derived) |
13/250 | Polio Anti Sabin type 33 (inactivated) Serum |
13/237 | Influenza Antigen B/Massachusetts/02/2115 (Egg derived) |
13/192 | C-Peptide, Human. 47st International Standard. |
13/286 | Polio Anti Sabin type 69 (inactivated) Serum |
95/568 | Interleukin-29 (Human, rDNA derived) |
95/583 | Interleukin-44 (Human, rDNA derived) |
13/236 | Polio Anti Sabin type 19 (inactivated) Serum |
13/306 | Polio Anti Sabin type 89 (inactivated) Serum |
95/587 | Interleukin-48 (Human, rDNA derived) |
10/170 | Reteplase Reference Material |
13/291 | Polio Anti Sabin type 74 (inactivated) Serum |
13/288 | Polio Anti Sabin type 71 (inactivated) Serum |
13/203 | C-Peptide, Human. 58st International Standard. |
03/104-123 | HTLV-108 (antibody) Monitor Sample |
07/317 | BCG Vaccine of Russian BCG-I sub-strain(44st WHO Reference Reagent) |
12/B623-079 | QCRFLUAH1N1QC1-Influenza AH1N1 QC77 |
13/213 | C-Peptide, Human. 68st International Standard. |
03/104-054 | HTLV-39 (antibody) Monitor Sample |
13/221 | C-Peptide, Human. 76st International Standard. |
13/196 | Influenza Antigen B/Massachusetts/02/2074 (Egg derived) |
13/224 | Polio Anti Sabin type 7 (inactivated) Serum |
95/634 | Interleukin-95 (Human, rDNA derived) |
10/130 | Reteplase Reference Material |
07/341 | BCG Vaccine of Russian BCG-I sub-strain(68st WHO Reference Reagent) |
13/233 | C-Peptide, Human. 88st International Standard. |
03/104-118 | HTLV-103 (antibody) Monitor Sample |
13/255 | Polio Anti Sabin type 38 (inactivated) Serum |
03/104-095 | HTLV-80 (antibody) Monitor Sample |
07/327 | BCG Vaccine of Russian BCG-I sub-strain(54st WHO Reference Reagent) |
95/593 | Interleukin-54 (Human, rDNA derived) |
95/608 | Interleukin-69 (Human, rDNA derived) |
10/147 | Reteplase Reference Material |
13/206 | Influenza Antigen B/Massachusetts/02/2084 (Egg derived) |
13/236 | Influenza Antigen B/Massachusetts/02/2114 (Egg derived) |
10/162 | Reteplase Reference Material |
01/460 | Meningococcal serogroup W polysaccharide |
13/220 | Polio Anti Sabin type 3 (inactivated) Serum |
13/196 | C-Peptide, Human. 51st International Standard. |
12/B623-092 | QCRFLUAH1N1QC1-Influenza AH1N1 QC90 |
10/207 | Reteplase Reference Material |
10/181 | Reteplase Reference Material |
12/B623-066 | QCRFLUAH1N1QC1-Influenza AH1N1 QC64 |
13/177 | C-Peptide, Human. 32st International Standard. |
13/183 | C-Peptide, Human. 38st International Standard. |
13/170 | Influenza Antigen B/Massachusetts/02/2048 (Egg derived) |
12/B623-037 | QCRFLUAH1N1QC1-Influenza AH1N1 QC35 |
95/610 | Interleukin-71 (Human, rDNA derived) |
95/636 | Interleukin-97 (Human, rDNA derived) |
10/115 | Reteplase Reference Material |
95/562 | Interleukin-23 (Human, rDNA derived) |
07/277 | BCG Vaccine of Russian BCG-I sub-strain(4st WHO Reference Reagent) |
95/557 | Interleukin-18 (Human, rDNA derived) |
07/289 | BCG Vaccine of Russian BCG-I sub-strain(16st WHO Reference Reagent) |
13/252 | Polio Anti Sabin type 35 (inactivated) Serum |
13/234 | C-Peptide, Human. 89st International Standard. |
13/144 | Influenza Antigen B/Massachusetts/02/2022 (Egg derived) |
07/367 | BCG Vaccine of Russian BCG-I sub-strain(94st WHO Reference Reagent) |
10/127 | Reteplase Reference Material |
07/329 | BCG Vaccine of Russian BCG-I sub-strain(56st WHO Reference Reagent) |
13/323 | Polio Anti Sabin type 106 (inactivated) Serum |
01/455 | Meningococcal serogroup W polysaccharide |
01/485 | Meningococcal serogroup W polysaccharide |
13/210 | C-Peptide, Human. 65st International Standard. |
13/234 | Influenza Antigen B/Massachusetts/02/2112 (Egg derived) |
12/B623-088 | QCRFLUAH1N1QC1-Influenza AH1N1 QC86 |
01/469 | Meningococcal serogroup W polysaccharide |
01/526 | Meningococcal serogroup W polysaccharide |
13/209 | Influenza Antigen B/Massachusetts/02/2087 (Egg derived) |
10/157 | Reteplase Reference Material |
13/226 | Polio Anti Sabin type 9 (inactivated) Serum |
13/238 | Polio Anti Sabin type 21 (inactivated) Serum |
10/174 | Reteplase Reference Material |
03/104-073 | HTLV-58 (antibody) Monitor Sample |
07/287 | BCG Vaccine of Russian BCG-I sub-strain(14st WHO Reference Reagent) |
10/189 | Reteplase Reference Material |
13/321 | Polio Anti Sabin type 104 (inactivated) Serum |
95/615 | Interleukin-76 (Human, rDNA derived) |
95/641 | Interleukin-102 (Human, rDNA derived) |
95/585 | Interleukin-46 (Human, rDNA derived) |
07/347 | BCG Vaccine of Russian BCG-I sub-strain(74st WHO Reference Reagent) |
10/108 | Reteplase Reference Material |
03/104-062 | HTLV-47 (antibody) Monitor Sample |
13/271 | Polio Anti Sabin type 54 (inactivated) Serum |
13/150 | C-Peptide, Human. 5st International Standard. |
13/241 | C-Peptide, Human. 96st International Standard. |
07/294 | BCG Vaccine of Russian BCG-I sub-strain(21st WHO Reference Reagent) |
13/214 | Influenza Antigen B/Massachusetts/02/2092 (Egg derived) |
13/191 | C-Peptide, Human. 46st International Standard. |
13/277 | Polio Anti Sabin type 60 (inactivated) Serum |
13/185 | C-Peptide, Human. 40st International Standard. |
13/294 | Polio Anti Sabin type 77 (inactivated) Serum |
13/156 | Influenza Antigen B/Massachusetts/02/2034 (Egg derived) |
01/449 | Meningococcal serogroup W polysaccharide |
07/313 | BCG Vaccine of Russian BCG-I sub-strain(40st WHO Reference Reagent) |
03/104-088 | HTLV-73 (antibody) Monitor Sample |
13/251 | C-Peptide, Human. 106st International Standard. |
03/104-036 | HTLV-21 (antibody) Monitor Sample |
10/120 | Reteplase Reference Material |
12/B623-031 | QCRFLUAH1N1QC1-Influenza AH1N1 QC29 |
13/228 | C-Peptide, Human. 83st International Standard. |
12/B623-041 | QCRFLUAH1N1QC1-Influenza AH1N1 QC39 |
10/118 | Reteplase Reference Material |
13/312 | Polio Anti Sabin type 95 (inactivated) Serum |
10/139 | Reteplase Reference Material |
95/618 | Interleukin-79 (Human, rDNA derived) |
12/B623-082 | QCRFLUAH1N1QC1-Influenza AH1N1 QC80 |
13/280 | Polio Anti Sabin type 63 (inactivated) Serum |
12/B623-094 | QCRFLUAH1N1QC1-Influenza AH1N1 QC92 |
07/282 | BCG Vaccine of Russian BCG-I sub-strain(9st WHO Reference Reagent) |
13/268 | Polio Anti Sabin type 51 (inactivated) Serum |
13/228 | Polio Anti Sabin type 11 (inactivated) Serum |
10/105 | Reteplase Reference Material |
13/270 | Polio Anti Sabin type 53 (inactivated) Serum |
95/644 | Interleukin-105 (Human, rDNA derived) |
13/186 | C-Peptide, Human. 41st International Standard. |
13/157 | C-Peptide, Human. 12st International Standard. |
13/309 | Polio Anti Sabin type 92 (inactivated) Serum |
13/137 | Influenza Antigen B/Massachusetts/02/2015 (Egg derived) |
12/B623-105 | QCRFLUAH1N1QC1-Influenza AH1N1 QC103 |
01/519 | Meningococcal serogroup W polysaccharide |
07/372 | BCG Vaccine of Russian BCG-I sub-strain(99st WHO Reference Reagent) |
95/579 | Interleukin-40 (Human, rDNA derived) |
13/207 | C-Peptide, Human. 62st International Standard. |
12/B623-015 | QCRFLUAH1N1QC1-Influenza AH1N1 QC13 |
13/233 | Influenza Antigen B/Massachusetts/02/2111 (Egg derived) |
13/209 | C-Peptide, Human. 64st International Standard. |
07/276 | BCG Vaccine of Russian BCG-I sub-strain(3st WHO Reference Reagent) |
95/658 | Interleukin-119 (Human, rDNA derived) |
07/346 | BCG Vaccine of Russian BCG-I sub-strain(73st WHO Reference Reagent) |
10/184 | Reteplase Reference Material |
12/B623-018 | QCRFLUAH1N1QC1-Influenza AH1N1 QC16 |
01/535 | Meningococcal serogroup W polysaccharide |
10/182 | Reteplase Reference Material |
03/104-016 | HTLV-1 (antibody) Monitor Sample |
13/219 | C-Peptide, Human. 74st International Standard. |
12/B623-078 | QCRFLUAH1N1QC1-Influenza AH1N1 QC76 |
13/197 | Influenza Antigen B/Massachusetts/02/2075 (Egg derived) |
03/104-116 | HTLV-101 (antibody) Monitor Sample |
95/639 | Interleukin-100 (Human, rDNA derived) |
03/104-082 | HTLV-67 (antibody) Monitor Sample |
07/286 | BCG Vaccine of Russian BCG-I sub-strain(13st WHO Reference Reagent) |
03/104-018 | HTLV-3 (antibody) Monitor Sample |
13/254 | Polio Anti Sabin type 37 (inactivated) Serum |
13/299 | Polio Anti Sabin type 82 (inactivated) Serum |
03/104-089 | HTLV-74 (antibody) Monitor Sample |
12/B623-084 | QCRFLUAH1N1QC1-Influenza AH1N1 QC82 |
13/176 | Influenza Antigen B/Massachusetts/02/2054 (Egg derived) |
95/627 | Interleukin-88 (Human, rDNA derived) |
12/B623-059 | QCRFLUAH1N1QC1-Influenza AH1N1 QC57 |
01/465 | Meningococcal serogroup W polysaccharide |
01/470 | Meningococcal serogroup W polysaccharide |
03/104-101 | HTLV-86 (antibody) Monitor Sample |
13/208 | C-Peptide, Human. 63st International Standard. |
95/559 | Interleukin-20 (Human, rDNA derived) |
01/451 | Meningococcal serogroup W polysaccharide |
13/174 | C-Peptide, Human. 29st International Standard. |
95/628 | Interleukin-89 (Human, rDNA derived) |
13/253 | C-Peptide, Human. 108st International Standard. |
01/481 | Meningococcal serogroup W polysaccharide |
13/236 | C-Peptide, Human. 91st International Standard. |
03/104-045 | HTLV-30 (antibody) Monitor Sample |
10/158 | Reteplase Reference Material |
03/104-079 | HTLV-64 (antibody) Monitor Sample |
03/104-066 | HTLV-51 (antibody) Monitor Sample |
10/210 | Reteplase Reference Material |
03/104-087 | HTLV-72 (antibody) Monitor Sample |
13/314 | Polio Anti Sabin type 97 (inactivated) Serum |
12/B623-077 | QCRFLUAH1N1QC1-Influenza AH1N1 QC75 |
01/528 | Meningococcal serogroup W polysaccharide |
01/529 | Meningococcal serogroup W polysaccharide |
13/256 | Polio Anti Sabin type 39 (inactivated) Serum |
01/527 | Meningococcal serogroup W polysaccharide |
13/199 | C-Peptide, Human. 54st International Standard. |
07/362 | BCG Vaccine of Russian BCG-I sub-strain(89st WHO Reference Reagent) |
13/303 | Polio Anti Sabin type 86 (inactivated) Serum |
07/363 | BCG Vaccine of Russian BCG-I sub-strain(90st WHO Reference Reagent) |
13/148 | C-Peptide, Human. 3st International Standard. |
07/368 | BCG Vaccine of Russian BCG-I sub-strain(95st WHO Reference Reagent) |
95/594 | Interleukin-55 (Human, rDNA derived) |
07/349 | BCG Vaccine of Russian BCG-I sub-strain(76st WHO Reference Reagent) |
95/622 | Interleukin-83 (Human, rDNA derived) |
12/B623-040 | QCRFLUAH1N1QC1-Influenza AH1N1 QC38 |
12/B623-025 | QCRFLUAH1N1QC1-Influenza AH1N1 QC23 |
10/165 | Reteplase Reference Material |
13/218 | Influenza Antigen B/Massachusetts/02/2096 (Egg derived) |
13/190 | Influenza Antigen B/Massachusetts/02/2068 (Egg derived) |
13/304 | Polio Anti Sabin type 87 (inactivated) Serum |
12/B623-083 | QCRFLUAH1N1QC1-Influenza AH1N1 QC81 |
12/B623-003 | QCRFLUAH1N1QC1-Influenza AH1N1 QC1 |
07/377 | BCG Vaccine of Russian BCG-I sub-strain(104st WHO Reference Reagent) |
12/B623-028 | QCRFLUAH1N1QC1-Influenza AH1N1 QC26 |
10/192 | Reteplase Reference Material |
13/296 | Polio Anti Sabin type 79 (inactivated) Serum |
95/575 | Interleukin-36 (Human, rDNA derived) |
13/235 | Polio Anti Sabin type 18 (inactivated) Serum |
07/328 | BCG Vaccine of Russian BCG-I sub-strain(55st WHO Reference Reagent) |
07/352 | BCG Vaccine of Russian BCG-I sub-strain(79st WHO Reference Reagent) |
07/342 | BCG Vaccine of Russian BCG-I sub-strain(69st WHO Reference Reagent) |
01/531 | Meningococcal serogroup W polysaccharide |
01/496 | Meningococcal serogroup W polysaccharide |
12/B623-033 | QCRFLUAH1N1QC1-Influenza AH1N1 QC31 |
13/229 | Polio Anti Sabin type 12 (inactivated) Serum |
03/104-060 | HTLV-45 (antibody) Monitor Sample |
13/278 | Polio Anti Sabin type 61 (inactivated) Serum |
95/595 | Interleukin-56 (Human, rDNA derived) |
13/139 | Influenza Antigen B/Massachusetts/02/2017 (Egg derived) |
03/104-070 | HTLV-55 (antibody) Monitor Sample |
03/104-039 | HTLV-24 (antibody) Monitor Sample |
13/315 | Polio Anti Sabin type 98 (inactivated) Serum |
13/221 | Influenza Antigen B/Massachusetts/02/2099 (Egg derived) |
13/193 | Influenza Antigen B/Massachusetts/02/2071 (Egg derived) |
01/438 | Meningococcal serogroup W polysaccharide |
01/505 | Meningococcal serogroup W polysaccharide |
01/490 | Meningococcal serogroup W polysaccharide |
07/343 | BCG Vaccine of Russian BCG-I sub-strain(70st WHO Reference Reagent) |
01/471 | Meningococcal serogroup W polysaccharide |
13/153 | C-Peptide, Human. 8st International Standard. |
13/138 | Influenza Antigen B/Massachusetts/02/2016 (Egg derived) |
03/104-052 | HTLV-37 (antibody) Monitor Sample |
01/472 | Meningococcal serogroup W polysaccharide |
07/374 | BCG Vaccine of Russian BCG-I sub-strain(101st WHO Reference Reagent) |
13/214 | C-Peptide, Human. 69st International Standard. |
13/248 | C-Peptide, Human. 103st International Standard. |
13/154 | C-Peptide, Human. 9st International Standard. |
10/166 | Reteplase Reference Material |
95/619 | Interleukin-80 (Human, rDNA derived) |
13/175 | Influenza Antigen B/Massachusetts/02/2053 (Egg derived) |
95/588 | Interleukin-49 (Human, rDNA derived) |
01/501 | Meningococcal serogroup W polysaccharide |
07/330 | BCG Vaccine of Russian BCG-I sub-strain(57st WHO Reference Reagent) |
03/104-091 | HTLV-76 (antibody) Monitor Sample |
13/218 | Polio Anti Sabin type 1 (inactivated) Serum |
03/104-110 | HTLV-95 (antibody) Monitor Sample |
10/112 | Reteplase Reference Material |
95/621 | Interleukin-82 (Human, rDNA derived) |
07/280 | BCG Vaccine of Russian BCG-I sub-strain(7st WHO Reference Reagent) |
01/453 | Meningococcal serogroup W polysaccharide |
13/177 | Influenza Antigen B/Massachusetts/02/2055 (Egg derived) |
13/200 | Influenza Antigen B/Massachusetts/02/2078 (Egg derived) |
12/B623-109 | QCRFLUAH1N1QC1-Influenza AH1N1 QC107 |
13/198 | Influenza Antigen B/Massachusetts/02/2076 (Egg derived) |
10/176 | Reteplase Reference Material |
03/104-099 | HTLV-84 (antibody) Monitor Sample |
95/577 | Interleukin-38 (Human, rDNA derived) |
03/104-064 | HTLV-49 (antibody) Monitor Sample |
01/475 | Meningococcal serogroup W polysaccharide |
13/245 | Polio Anti Sabin type 28 (inactivated) Serum |
03/104-065 | HTLV-50 (antibody) Monitor Sample |
13/148 | Influenza Antigen B/Massachusetts/02/2026 (Egg derived) |
07/295 | BCG Vaccine of Russian BCG-I sub-strain(22st WHO Reference Reagent) |
13/206 | C-Peptide, Human. 61st International Standard. |
03/104-100 | HTLV-85 (antibody) Monitor Sample |
95/653 | Interleukin-114 (Human, rDNA derived) |
07/326 | BCG Vaccine of Russian BCG-I sub-strain(53st WHO Reference Reagent) |
13/237 | C-Peptide, Human. 92st International Standard. |
13/180 | C-Peptide, Human. 35st International Standard. |
13/227 | C-Peptide, Human. 82st International Standard. |
13/156 | C-Peptide, Human. 11st International Standard. |
01/484 | Meningococcal serogroup W polysaccharide |
10/186 | Reteplase Reference Material |
13/307 | Polio Anti Sabin type 90 (inactivated) Serum |
95/586 | Interleukin-47 (Human, rDNA derived) |
12/B623-034 | QCRFLUAH1N1QC1-Influenza AH1N1 QC32 |
12/B623-004 | QCRFLUAH1N1QC1-Influenza AH1N1 QC2 |
13/235 | Influenza Antigen B/Massachusetts/02/2113 (Egg derived) |
13/228 | Influenza Antigen B/Massachusetts/02/2106 (Egg derived) |
95/659 | Interleukin-120 (Human, rDNA derived) |
12/B623-095 | QCRFLUAH1N1QC1-Influenza AH1N1 QC93 |
10/143 | Reteplase Reference Material |
01/473 | Meningococcal serogroup W polysaccharide |
07/322 | BCG Vaccine of Russian BCG-I sub-strain(49st WHO Reference Reagent) |
10/156 | Reteplase Reference Material |
10/149 | Reteplase Reference Material |
01/497 | Meningococcal serogroup W polysaccharide |
95/652 | Interleukin-113 (Human, rDNA derived) |
13/171 | C-Peptide, Human. 26st International Standard. |
13/157 | Influenza Antigen B/Massachusetts/02/2035 (Egg derived) |
13/322 | Polio Anti Sabin type 105 (inactivated) Serum |
13/240 | Influenza Antigen B/Massachusetts/02/2118 (Egg derived) |
10/119 | Reteplase Reference Material |
13/159 | C-Peptide, Human. 14st International Standard. |
01/525 | Meningococcal serogroup W polysaccharide |
13/158 | C-Peptide, Human. 13st International Standard. |
03/104-059 | HTLV-44 (antibody) Monitor Sample |
10/171 | Reteplase Reference Material |
10/202 | Reteplase Reference Material |
12/B623-017 | QCRFLUAH1N1QC1-Influenza AH1N1 QC15 |
13/292 | Polio Anti Sabin type 75 (inactivated) Serum |
01/491 | Meningococcal serogroup W polysaccharide |
07/376 | BCG Vaccine of Russian BCG-I sub-strain(103st WHO Reference Reagent) |
13/211 | C-Peptide, Human. 66st International Standard. |
03/104-121 | HTLV-106 (antibody) Monitor Sample |
03/104-035 | HTLV-20 (antibody) Monitor Sample |
03/104-046 | HTLV-31 (antibody) Monitor Sample |
13/302 | Polio Anti Sabin type 85 (inactivated) Serum |
13/162 | Influenza Antigen B/Massachusetts/02/2040 (Egg derived) |
13/222 | C-Peptide, Human. 77st International Standard. |
13/258 | Polio Anti Sabin type 41 (inactivated) Serum |
10/148 | Reteplase Reference Material |
01/509 | Meningococcal serogroup W polysaccharide |
13/142 | Influenza Antigen B/Massachusetts/02/2020 (Egg derived) |
01/533 | Meningococcal serogroup W polysaccharide |
07/380 | BCG Vaccine of Russian BCG-I sub-strain(107st WHO Reference Reagent) |
95/617 | Interleukin-78 (Human, rDNA derived) |
07/320 | BCG Vaccine of Russian BCG-I sub-strain(47st WHO Reference Reagent) |
12/B623-007 | QCRFLUAH1N1QC1-Influenza AH1N1 QC5 |
12/B623-013 | QCRFLUAH1N1QC1-Influenza AH1N1 QC11 |
95/592 | Interleukin-53 (Human, rDNA derived) |
95/598 | Interleukin-59 (Human, rDNA derived) |
12/B623-100 | QCRFLUAH1N1QC1-Influenza AH1N1 QC98 |
13/233 | Polio Anti Sabin type 16 (inactivated) Serum |
01/439 | Meningococcal serogroup W polysaccharide |
07/303 | BCG Vaccine of Russian BCG-I sub-strain(30st WHO Reference Reagent) |
13/224 | C-Peptide, Human. 79st International Standard. |
01/436 | Meningococcal serogroup W polysaccharide |
12/B623-110 | QCRFLUAH1N1QC1-Influenza AH1N1 QC108 |
12/B623-072 | QCRFLUAH1N1QC1-Influenza AH1N1 QC70 |
13/195 | Influenza Antigen B/Massachusetts/02/2073 (Egg derived) |
10/106 | Reteplase Reference Material |
01/446 | Meningococcal serogroup W polysaccharide |
12/B623-107 | QCRFLUAH1N1QC1-Influenza AH1N1 QC105 |
12/B623-089 | QCRFLUAH1N1QC1-Influenza AH1N1 QC87 |
07/356 | BCG Vaccine of Russian BCG-I sub-strain(83st WHO Reference Reagent) |
13/187 | C-Peptide, Human. 42st International Standard. |
03/104-098 | HTLV-83 (antibody) Monitor Sample |
95/599 | Interleukin-60 (Human, rDNA derived) |
13/220 | C-Peptide, Human. 75st International Standard. |
03/104-104 | HTLV-89 (antibody) Monitor Sample |
03/104-025 | HTLV-10 (antibody) Monitor Sample |
10/201 | Reteplase Reference Material |
03/104-044 | HTLV-29 (antibody) Monitor Sample |
95/569 | Interleukin-30 (Human, rDNA derived) |
10/129 | Reteplase Reference Material |
01/444 | Meningococcal serogroup W polysaccharide |
07/307 | BCG Vaccine of Russian BCG-I sub-strain(34st WHO Reference Reagent) |
01/450 | Meningococcal serogroup W polysaccharide |
10/161 | Reteplase Reference Material |
10/172 | Reteplase Reference Material |
07/378 | BCG Vaccine of Russian BCG-I sub-strain(105st WHO Reference Reagent) |
03/104-069 | HTLV-54 (antibody) Monitor Sample |
95/582 | Interleukin-43 (Human, rDNA derived) |
01/435 | Meningococcal serogroup W polysaccharide |
10/195 | Reteplase Reference Material |
13/169 | C-Peptide, Human. 24st International Standard. |
03/104-031 | HTLV-16 (antibody) Monitor Sample |
07/293 | BCG Vaccine of Russian BCG-I sub-strain(20st WHO Reference Reagent) |
13/184 | C-Peptide, Human. 39st International Standard. |
13/159 | Influenza Antigen B/Massachusetts/02/2037 (Egg derived) |
13/216 | C-Peptide, Human. 71st International Standard. |
03/104-078 | HTLV-63 (antibody) Monitor Sample |
07/312 | BCG Vaccine of Russian BCG-I sub-strain(39st WHO Reference Reagent) |
13/281 | Polio Anti Sabin type 64 (inactivated) Serum |
03/104-105 | HTLV-90 (antibody) Monitor Sample |
01/454 | Meningococcal serogroup W polysaccharide |
13/215 | C-Peptide, Human. 70st International Standard. |
07/344 | BCG Vaccine of Russian BCG-I sub-strain(71st WHO Reference Reagent) |
13/230 | Polio Anti Sabin type 13 (inactivated) Serum |
13/223 | C-Peptide, Human. 78st International Standard. |
10/204 | Reteplase Reference Material |
01/458 | Meningococcal serogroup W polysaccharide |
95/633 | Interleukin-94 (Human, rDNA derived) |
10/123 | Reteplase Reference Material |
13/317 | Polio Anti Sabin type 100 (inactivated) Serum |
07/310 | BCG Vaccine of Russian BCG-I sub-strain(37st WHO Reference Reagent) |
13/224 | Influenza Antigen B/Massachusetts/02/2102 (Egg derived) |
13/136 | Influenza Antigen B/Massachusetts/02/2014 (Egg derived) |
13/257 | Polio Anti Sabin type 40 (inactivated) Serum |
07/331 | BCG Vaccine of Russian BCG-I sub-strain(58st WHO Reference Reagent) |
03/104-103 | HTLV-88 (antibody) Monitor Sample |
07/306 | BCG Vaccine of Russian BCG-I sub-strain(33st WHO Reference Reagent) |
13/225 | Influenza Antigen B/Massachusetts/02/2103 (Egg derived) |
03/104-024 | HTLV-9 (antibody) Monitor Sample |
03/104-019 | HTLV-4 (antibody) Monitor Sample |
12/B623-012 | QCRFLUAH1N1QC1-Influenza AH1N1 QC10 |
03/104-021 | HTLV-6 (antibody) Monitor Sample |
01/498 | Meningococcal serogroup W polysaccharide |
12/B623-060 | QCRFLUAH1N1QC1-Influenza AH1N1 QC58 |
13/194 | C-Peptide, Human. 49st International Standard. |
13/301 | Polio Anti Sabin type 84 (inactivated) Serum |
95/567 | Interleukin-28 (Human, rDNA derived) |
95/555 | Interleukin-16 (Human, rDNA derived) |
10/199 | Reteplase Reference Material |
10/134 | Reteplase Reference Material |
95/609 | Interleukin-70 (Human, rDNA derived) |
10/173 | Reteplase Reference Material |
13/324 | Polio Anti Sabin type 107 (inactivated) Serum |
10/150 | Reteplase Reference Material |
01/480 | Meningococcal serogroup W polysaccharide |
01/474 | Meningococcal serogroup W polysaccharide |
01/511 | Meningococcal serogroup W polysaccharide |
01/492 | Meningococcal serogroup W polysaccharide |
13/200 | C-Peptide, Human. 55st International Standard. |
13/167 | C-Peptide, Human. 22st International Standard. |
95/616 | Interleukin-77 (Human, rDNA derived) |
07/324 | BCG Vaccine of Russian BCG-I sub-strain(51st WHO Reference Reagent) |
12/B623-044 | QCRFLUAH1N1QC1-Influenza AH1N1 QC42 |
13/223 | Influenza Antigen B/Massachusetts/02/2101 (Egg derived) |
95/623 | Interleukin-84 (Human, rDNA derived) |
95/626 | Interleukin-87 (Human, rDNA derived) |
07/369 | BCG Vaccine of Russian BCG-I sub-strain(96st WHO Reference Reagent) |
13/212 | C-Peptide, Human. 67st International Standard. |
01/468 | Meningococcal serogroup W polysaccharide |
13/164 | C-Peptide, Human. 19st International Standard. |
01/524 | Meningococcal serogroup W polysaccharide |
03/104-032 | HTLV-17 (antibody) Monitor Sample |
03/104-094 | HTLV-79 (antibody) Monitor Sample |
07/339 | BCG Vaccine of Russian BCG-I sub-strain(66st WHO Reference Reagent) |
12/B623-063 | QCRFLUAH1N1QC1-Influenza AH1N1 QC61 |
13/264 | Polio Anti Sabin type 47 (inactivated) Serum |
13/211 | Influenza Antigen B/Massachusetts/02/2089 (Egg derived) |
01/429 | Meningococcal serogroup W polysaccharide |
13/305 | Polio Anti Sabin type 88 (inactivated) Serum |
95/584 | Interleukin-45 (Human, rDNA derived) |
95/612 | Interleukin-73 (Human, rDNA derived) |
13/260 | Polio Anti Sabin type 43 (inactivated) Serum |
13/191 | Influenza Antigen B/Massachusetts/02/2069 (Egg derived) |
13/235 | C-Peptide, Human. 90st International Standard. |
01/499 | Meningococcal serogroup W polysaccharide |
13/219 | Influenza Antigen B/Massachusetts/02/2097 (Egg derived) |
01/441 | Meningococcal serogroup W polysaccharide |
13/203 | Influenza Antigen B/Massachusetts/02/2081 (Egg derived) |
12/B623-052 | QCRFLUAH1N1QC1-Influenza AH1N1 QC50 |
13/217 | Influenza Antigen B/Massachusetts/02/2095 (Egg derived) |
03/104-068 | HTLV-53 (antibody) Monitor Sample |
13/223 | Polio Anti Sabin type 6 (inactivated) Serum |
13/316 | Polio Anti Sabin type 99 (inactivated) Serum |
95/655 | Interleukin-116 (Human, rDNA derived) |
12/B623-096 | QCRFLUAH1N1QC1-Influenza AH1N1 QC94 |
12/B623-108 | QCRFLUAH1N1QC1-Influenza AH1N1 QC106 |
95/580 | Interleukin-41 (Human, rDNA derived) |
12/B623-036 | QCRFLUAH1N1QC1-Influenza AH1N1 QC34 |
13/192 | Influenza Antigen B/Massachusetts/02/2070 (Egg derived) |
13/248 | Polio Anti Sabin type 31 (inactivated) Serum |
13/318 | Polio Anti Sabin type 101 (inactivated) Serum |
07/365 | BCG Vaccine of Russian BCG-I sub-strain(92st WHO Reference Reagent) |
13/265 | Polio Anti Sabin type 48 (inactivated) Serum |
07/296 | BCG Vaccine of Russian BCG-I sub-strain(23st WHO Reference Reagent) |
07/371 | BCG Vaccine of Russian BCG-I sub-strain(98st WHO Reference Reagent) |
13/243 | C-Peptide, Human. 98st International Standard. |
12/B623-058 | QCRFLUAH1N1QC1-Influenza AH1N1 QC56 |
01/448 | Meningococcal serogroup W polysaccharide |
13/231 | Influenza Antigen B/Massachusetts/02/2109 (Egg derived) |
07/283 | BCG Vaccine of Russian BCG-I sub-strain(10st WHO Reference Reagent) |
13/263 | Polio Anti Sabin type 46 (inactivated) Serum |
13/261 | Polio Anti Sabin type 44 (inactivated) Serum |
13/189 | Influenza Antigen B/Massachusetts/02/2067 (Egg derived) |
10/208 | Reteplase Reference Material |
03/104-081 | HTLV-66 (antibody) Monitor Sample |
12/B623-068 | QCRFLUAH1N1QC1-Influenza AH1N1 QC66 |
13/250 | C-Peptide, Human. 105st International Standard. |
12/B623-070 | QCRFLUAH1N1QC1-Influenza AH1N1 QC68 |
07/275 | BCG Vaccine of Russian BCG-I sub-strain(2st WHO Reference Reagent) |
13/212 | Influenza Antigen B/Massachusetts/02/2090 (Egg derived) |
95/654 | Interleukin-115 (Human, rDNA derived) |
12/B623-090 | QCRFLUAH1N1QC1-Influenza AH1N1 QC88 |
01/532 | Meningococcal serogroup W polysaccharide |
10/163 | Reteplase Reference Material |
95/649 | Interleukin-110 (Human, rDNA derived) |
03/104-041 | HTLV-26 (antibody) Monitor Sample |
13/227 | Influenza Antigen B/Massachusetts/02/2105 (Egg derived) |
01/443 | Meningococcal serogroup W polysaccharide |
10/111 | Reteplase Reference Material |
01/428 | Meningococcal serogroup W polysaccharide |
01/479 | Meningococcal serogroup W polysaccharide |
12/B623-043 | QCRFLUAH1N1QC1-Influenza AH1N1 QC41 |
07/351 | BCG Vaccine of Russian BCG-I sub-strain(78st WHO Reference Reagent) |
07/318 | BCG Vaccine of Russian BCG-I sub-strain(45st WHO Reference Reagent) |
07/358 | BCG Vaccine of Russian BCG-I sub-strain(85st WHO Reference Reagent) |
12/B623-102 | QCRFLUAH1N1QC1-Influenza AH1N1 QC100 |
12/B623-042 | QCRFLUAH1N1QC1-Influenza AH1N1 QC40 |
03/104-122 | HTLV-107 (antibody) Monitor Sample |
01/464 | Meningococcal serogroup W polysaccharide |
07/291 | BCG Vaccine of Russian BCG-I sub-strain(18st WHO Reference Reagent) |
10/136 | Reteplase Reference Material |
13/155 | Influenza Antigen B/Massachusetts/02/2033 (Egg derived) |
95/646 | Interleukin-107 (Human, rDNA derived) |
10/140 | Reteplase Reference Material |
95/650 | Interleukin-111 (Human, rDNA derived) |
01/518 | Meningococcal serogroup W polysaccharide |
95/604 | Interleukin-65 (Human, rDNA derived) |
10/145 | Reteplase Reference Material |
13/237 | Polio Anti Sabin type 20 (inactivated) Serum |
13/298 | Polio Anti Sabin type 81 (inactivated) Serum |
12/B623-076 | QCRFLUAH1N1QC1-Influenza AH1N1 QC74 |
13/160 | Influenza Antigen B/Massachusetts/02/2038 (Egg derived) |
07/299 | BCG Vaccine of Russian BCG-I sub-strain(26st WHO Reference Reagent) |
01/530 | Meningococcal serogroup W polysaccharide |
10/144 | Reteplase Reference Material |
10/116 | Reteplase Reference Material |
12/B623-019 | QCRFLUAH1N1QC1-Influenza AH1N1 QC17 |
13/183 | Influenza Antigen B/Massachusetts/02/2061 (Egg derived) |
13/158 | Influenza Antigen B/Massachusetts/02/2036 (Egg derived) |
12/B623-081 | QCRFLUAH1N1QC1-Influenza AH1N1 QC79 |
12/B623-085 | QCRFLUAH1N1QC1-Influenza AH1N1 QC83 |
10/114 | Reteplase Reference Material |
07/316 | BCG Vaccine of Russian BCG-I sub-strain(43st WHO Reference Reagent) |
95/645 | Interleukin-106 (Human, rDNA derived) |
01/433 | Meningococcal serogroup W polysaccharide |
12/B623-039 | QCRFLUAH1N1QC1-Influenza AH1N1 QC37 |
13/259 | Polio Anti Sabin type 42 (inactivated) Serum |
07/350 | BCG Vaccine of Russian BCG-I sub-strain(77st WHO Reference Reagent) |
03/104-120 | HTLV-105 (antibody) Monitor Sample |
12/B623-101 | QCRFLUAH1N1QC1-Influenza AH1N1 QC99 |
95/554 | Interleukin-15 (Human, rDNA derived) |
13/246 | C-Peptide, Human. 101st International Standard. |
13/207 | Influenza Antigen B/Massachusetts/02/2085 (Egg derived) |
13/172 | C-Peptide, Human. 27st International Standard. |
12/B623-030 | QCRFLUAH1N1QC1-Influenza AH1N1 QC28 |
13/290 | Polio Anti Sabin type 73 (inactivated) Serum |
07/281 | BCG Vaccine of Russian BCG-I sub-strain(8st WHO Reference Reagent) |
13/179 | Influenza Antigen B/Massachusetts/02/2057 (Egg derived) |
95/657 | Interleukin-118 (Human, rDNA derived) |
03/104-109 | HTLV-94 (antibody) Monitor Sample |
13/181 | C-Peptide, Human. 36st International Standard. |
07/288 | BCG Vaccine of Russian BCG-I sub-strain(15st WHO Reference Reagent) |
13/182 | Influenza Antigen B/Massachusetts/02/2060 (Egg derived) |
01/520 | Meningococcal serogroup W polysaccharide |
07/337 | BCG Vaccine of Russian BCG-I sub-strain(64st WHO Reference Reagent) |
95/570 | Interleukin-31 (Human, rDNA derived) |
13/238 | Influenza Antigen B/Massachusetts/02/2116 (Egg derived) |
95/648 | Interleukin-109 (Human, rDNA derived) |
12/B623-071 | QCRFLUAH1N1QC1-Influenza AH1N1 QC69 |
10/197 | Reteplase Reference Material |
01/467 | Meningococcal serogroup W polysaccharide |
12/B623-022 | QCRFLUAH1N1QC1-Influenza AH1N1 QC20 |
10/138 | Reteplase Reference Material |
12/B623-047 | QCRFLUAH1N1QC1-Influenza AH1N1 QC45 |
95/571 | Interleukin-32 (Human, rDNA derived) |
95/629 | Interleukin-90 (Human, rDNA derived) |
10/110 | Reteplase Reference Material |
10/104 | Reteplase Reference Material |
03/104-113 | HTLV-98 (antibody) Monitor Sample |
01/502 | Meningococcal serogroup W polysaccharide |
01/521 | Meningococcal serogroup W polysaccharide |
03/104-077 | HTLV-62 (antibody) Monitor Sample |